Catalyst Wire Dossier Catalyst Wire Dossier

APD-209 Eye Drops

APD-209 · Adenovir Pharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APD-209 Eye Drops, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) [Phase 2]

See pricing